Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001797826-26-000002

Director acquired 6,408 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Thornberry Nancy Director 2026-06-03 Grant or award +6,408 31,125 D
Derivatives
Thornberry Nancy Director 2026-06-03 Grant or award · Stock Option (right to buy) +19,226 19,226 D
Loading xslF345X06/wk-form4_1780692307.xml…